This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: River Stone Biotech LLC. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Sure, here is the article about inventor Fanny Delgrange:
Title: Inventor Spotlight: Fanny Delgrange
Introduction: Meet Fanny Delgrange, a talented inventor hailing from Hagenthal-le-Haut, France, who has made significant contributions to the field of biosynthesis.
Latest Patents: Fanny Delgrange has garnered attention with his latest patents focusing on the increased biosynthesis of benzylisoquinoline alkaloids and their precursors. These patents involve the engineering of recombinant host cells to enhance production by reducing the levels or activity of specific enzymes, such as alcohol dehydrogenases or aldehyde reductases.
Career Highlights: Fanny Delgrange is an integral member of River Stone Biotech LLC, a company known for its innovative approach to biotechnology. Through his work, he has demonstrated a keen understanding of genetic engineering and its applications in enhancing biosynthesis processes.
Collaborations: In his endeavors, Fanny Delgrange has collaborated closely with esteemed colleagues such as Esben Halkjaer Hansen and Franziska Grassinger. Together, they have pushed the boundaries of biotech innovation and have set new standards in the industry.
Conclusion: Fanny Delgrange's dedication to advancing biosynthesis technologies shines through in his patent portfolio and contributions to the field. His innovative spirit and collaborative nature continue to drive progress and shape the future of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile